Published in Drug Law Weekly, March 20th, 2012
"Results obtained using spectroscopic methods strongly suggested that the ligand and its Cu(II)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.